Shares of Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM), a bio-pharmaceutical with a portfolio of cancer and infectious disease antibodies in clinical trials, has until September 24 to get their penny stock price above $1 or face being delisted from the Nasdaq. PPHM hit a 52 week low but managed to gain nearly 2% in the last trading session to close at $0.426 on volume ...
22
APR
APR
0
Share
